Nuveen
MAIA icon

Nuveen’s MAIA Biotechnology MAIA Stock Holding History

Nuveen’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.71K Buy
+2,357
New +$3.17K ﹤0.01% 4797

Other funds holding MAIA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
Lazari Capital Management
Lazari Capital Management Woodland Hills, California $339M AUM 25.58% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Centerpoint Advisory Group
Centerpoint Advisory Group Overland Park, Kansas $161M AUM 19.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Nuveen's MAIA Position: Q3 2026 in Review

Nuveen opened a new position in MAIA Biotechnology (MAIA) in Q3 2026: 2,357 shares worth $2.71K. The stake represents ﹤0.01% of the portfolio and ranks #4797 among its holdings.

12 funds tracked by Wall St. Rank hold MAIA as of Q3 2026.

  • Nuveen held 2,357 shares of MAIA Biotechnology worth $2.71K as of Q3 2026.
  • MAIA Biotechnology was a new Nuveen position in Q3 2026.
  • MAIA Biotechnology made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4797 holding.
  • 12 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.